The Recall Desk
HighFDA (Devices)·Z-0709-2022·Announced 2022-03-09

Lacrimedics Collagen Plugs recalled for potential sterility seal compromise

Lacrimedics is recalling Collagen Plugs (models CP3, CP4, CP5) due to potential seal integrity defects in sterile pouches. The seals may contain channels that could compromise sterility and allow contamination.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: FDA Class II recall involving a sterile medical device where compromised seal integrity could lead to contamination and infection risk. No illnesses or injuries have been reported, qualifying this as a risk-of-harm product where injury has not yet been reported.

Plain-English summary

Lacrimedics Inc. is recalling Collagen Plugs (models CP3 0.3mm, CP4 0.4mm, and CP5 0.5mm) distributed nationwide and internationally. The recall affects 4,780 units of this sterile, prescription-only medical device used for dry eye treatment.

The sterile pouch seals may contain channels that could affect seal integrity and potentially compromise sterility. This defect could allow contamination to enter the sealed package, affecting the safety of the product.

The affected devices were distributed to numerous countries including Argentina, Belgium, Bolivia, Brazil, Switzerland, China, Colombia, Czech Republic, Germany, Ecuador, Spain, Finland, Georgia, India, Israel, Malaysia, Mexico, New Zealand, Peru, Romania, Singapore, Saudi Arabia, Turkey, Taiwan, Tanzania, and the United Kingdom. Patients and healthcare providers should discontinue use of the recalled devices immediately.

Patients currently using these plugs should consult their healthcare provider about the recall. Healthcare providers should contact Lacrimedics Inc. for information regarding replacement products or alternative treatment options.

The recalled product

Product
Collagen Plugs, CP3, 0.3mm, CP4, 0.4mm, CP5, 0.5 mm, Sterile, EO, Rx Only, CE Dry eye treatment
Manufacturer
Lacrimedics Inc
Hazard
  • seal-integrity
  • sterility-compromise
  • contamination-risk

Distribution

Distributed nationwide across the United States.